TradeIL Korea in partnership with TradeIL Australia is pleased to invite you to the webinar, “Trends and Innovations Emerging from Israel’s Pharmaceutical and Healthcare Ecosystem.”
Join us to explore how Israeli biotechnology and healthcare companies are leveraging artificial intelligence to transform drug discovery, diagnostics, and the future of healthcare.
[When?]
July 6, 2026 (Monday), 4:30–5:30 PM AEST (9:30–10:30 AM Israel Time)
[What?]
16:30-16:50 – Welcome Remarks & Keynote –
“How AI is Shaping Our Healthcare and Future Pharma Landscape”: Aion Labs (Mati Gill, CEO & Founder)
16:50-17:30 – Followed by 3 company presentations:
1) CytoReason (Elina Starosvetsky, CEO & Co-founder) – CytoReason’s AI-powered disease models turn complex molecular and clinical data into smarter Phase 2 decisions-helping pharma partners de-risk programs and improve the odds of clinical success.
2) Protai (Eran Seger, CEO & Founder) – Protai combines artificial intelligence and proteomics to uncover novel drug targets and biomarkers, enabling faster and more precise development of next-generation therapeutics.
3) Scopio Labs (Amir Farhi, CCO): Al-powered, Full-Field digital cell morphology platform.
- Q&A Session
Zoom registration: https://us02web.zoom.us/webinar/register/WN_bfbygfVMSn-mwVmpgyc-zg#/registration
Discover more from
Subscribe to get the latest posts sent to your email.
